Aprea Therapeutics, Inc. - Common Stock (APRE)

CUSIP: 03836J201

Q1 2024 13F Holders as of 31 Mar 2024

Holder snapshot 6 signals
Share change
+697,614
SEC-reported price per share
$6.69
Number of holders
22
Value change
+$4,966,764
Number of buys
12
Number of sells
6
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
12,212,719

Security key

03836J201

Report period

Q1 2024

Institutions

22

Top holders

10

Ownership snapshot

Top reported holders of APRE - Aprea Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
AIGH Capital Management LLC
Disclosed value leader
AIGH Capital Management LLC
Comparable rows
0/15
Latest evidence
31 Dec 2023
13F 3/4/5 Highest disclosed value: $1,641,710 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

AIGH Capital Management LLC has the largest disclosed position value at $1.64M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens AIGH Capital Management LLC's linked filing trail.
Disclosed position value Top 5
AIGH Capital Management LLC $1.64M
Sio Capital Management, LLC $1.32M
Christian S. Schade $976.3K
Scott M. Coiante $534K
Worth Venture Partners, LLC $409.7K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
AIGH Capital Management LLC
13F
Company
13F
—
denominator unverified
$1,641,710
349,300 shares
— 31 Dec 2023
Sio Capital Management, LLC
13F
Company
13F
—
denominator unverified
$1,316,000
280,000 shares
— 31 Dec 2023
Christian S. Schade
3/4/5
Director
—
mixed-class rows
$976,345
312,846 shares
mixed-class rows
— 28 Jul 2022
Scott M. Coiante
3/4/5
SVP, Chief Financial Officer
—
mixed-class rows
$533,970
234,265 shares
mixed-class rows
— 28 Jul 2022
Worth Venture Partners, LLC
13F
Company
13F
—
denominator unverified
$409,694
87,169 shares
— 31 Dec 2023
Walleye Capital LLC
13F
Company
13F
—
denominator unverified
$376,000
80,000 shares
— 31 Dec 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
22
Shares
1,624,394
Rows available
22
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q2 2026 Across Filers

Q2 2026 holders
27
Q1 2024 holders
22
Holder diff
-5
Investor Q2 2026 Shares Q1 2024 Shares Share Diff Share Chg % Q2 2026 value Q1 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .